BIO-CAT Microbials, LLC
About
Company description
Since 1988, BIO-CAT has been the enzyme industry
leader. Today they are also the leading Bacillus experts. BIO-CAT’s
driven purpose is to partner with brilliant people who want to improve human
and animal nutrition, water, soil, and more through innovative applications of
enzymes and microbials. Taking ideas from incubation through every stage of development
to achieve their fullest potential, BIO-CAT and BIO-CAT Microbials offer a
carefully curated portfolio of natural, non-genetically engineered enzymes and
microbials for custom enzyme solutions and probiotic product innovation.
BIO-CAT Microbials is proud of their continually
expanding library of well-characterized Bacillus strains for Human
Health, Animal Nutrition, and sustainable Crop Science. These strains are
produced in BIO-CAT's fully-integrated U.S. fermentation facility in Minnesota,
and are available to strategic partners for discovery and product development
projects.
Quick facts
| Sales markets | Africa; Asia; Central/South America; North America; Western Europe |
|---|---|
| Primary business activity | Manufacturer: Ingredients / Additives |
| Affiliated categories: | Clinical trials |Contract manufacturing |Enzymes More |
Upcoming events
Fi Europe 2024
19 - 21 Nov 2024 Frankfurt, Germany Visit us at stand 3.1M37 Book a meeting See our Exhibitor Profile See full Exhibitor ListRecently at
Vitafoods Europe 2024
14 - 16 May 2024 - Geneva, Switzerland We were at stand L232G See our Exhibitor Profile See full Exhibitor ListOur Top products
News about BIO-CAT Microbials, LLC
10 Nov 2022
BIO-CAT Microbials Invests $35 Million in State-of-the-Art Virginia Fermentation Facility
March 2022 | BIO-CAT and BIO-CAT Microbials recently announced a $35 million investment to significantly expand its Troy, Virginia facility to include fermentation capabilities. The company will be breaking ground on an initial 53,800 square-foot expansion phase in March of 2022, with potential future expansion up to an additional 100,000 square feet.
Read more10 Nov 2022
BIO-CAT Microbials Publishes Paper on Proprietary New Bacillus Strain
October 2022 | BIO-CAT Microbials is proud to announce the release of their most recent publication in Gut Microbes. This publication discusses the promising results of BIO-CAT Microbials’ clinical trial executed in collaboration with Biofortis Inc. a subsidiary of Mérieux NutriSciences.
Read more10 Nov 2022
BIO-CAT Microbials Publishes Safety Manuscript on Proprietary New Bacillus Strain
May 2022 | BIO-CAT Microbials continues to scale up their probiotic pipeline with their latest microbial strain, Bacillus subtilis BS50. This strain was identified as the top contender after undergoing a rigorous and competitive screening against several thousand strains held within BIO-CAT's propriety library.
Read more